These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [The therapeutic benefits of systemic treatment of psoriatic arthritis? The example of golimumab in psoriatic arthritis]. Boulinguez S; Sibilia J Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H11-5. PubMed ID: 21703459 [No Abstract] [Full Text] [Related]
10. Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study. McInnes IB; Mease PJ; Ritchlin CT; Rahman P; Gottlieb AB; Kirkham B; Kajekar R; Delicha EM; Pricop L; Mpofu S Rheumatology (Oxford); 2017 Nov; 56(11):1993-2003. PubMed ID: 28968735 [TBL] [Abstract][Full Text] [Related]
11. Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment. Nikas SN; Voulgari PV; Takalou IP; Katsimbri P; Drosos AA Ann Rheum Dis; 2005 Nov; 64(11):1665-7. PubMed ID: 16227426 [No Abstract] [Full Text] [Related]
12. Long term treatment of psoriatic arthritis with infliximab. Yazdani-Biuki B; Wohlfahrt K; Mulabecirovic A; Mueller T; Hermann J; Graninger WB; Brezinschek HP; Brezinschek RI Ann Rheum Dis; 2004 Nov; 63(11):1531-2; author reply 1532. PubMed ID: 15479917 [No Abstract] [Full Text] [Related]
13. [Adalimumab in arthritis psoriatica]. Szekanecz Z Orv Hetil; 2009 Jul; 150(30):1423. PubMed ID: 19592338 [No Abstract] [Full Text] [Related]
14. Is there a need for new agents with novel mechanisms of action in psoriatic arthritis? Orr C; Veale DJ Ann Rheum Dis; 2014 Jun; 73(6):951-3. PubMed ID: 24790066 [No Abstract] [Full Text] [Related]
15. Long term infliximab treatment for severe psoriatic arthritis: evidence of sustained clinical and radiographic response. Rinaldi F; Provenzano G; Termini A; Spinello M; La Seta F Ann Rheum Dis; 2005 Sep; 64(9):1375-6. PubMed ID: 16100346 [No Abstract] [Full Text] [Related]
16. Psoriatic arthritis patients doing better on infliximab than etanercept. Smith N; Gadsby K; Deighton C Rheumatology (Oxford); 2007 Apr; 46(4):721-2. PubMed ID: 17314216 [No Abstract] [Full Text] [Related]
17. Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? Rossini M; Viapiana O; Orsolini G; Fracassi E; Idolazzi L; Gatti D; Adami S; Govoni M Reumatismo; 2015 Mar; 66(4):285-303. PubMed ID: 25829189 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of infliximab for the treatment of psoriatic arthritis. Ritchlin C Nat Clin Pract Rheumatol; 2006 Jun; 2(6):300-1. PubMed ID: 16932707 [No Abstract] [Full Text] [Related]
20. Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo. Vander Cruyssen B; De Keyser F; Kruithof E; Mielants H; Van den Bosch F Ann Rheum Dis; 2007 Jan; 66(1):138-40. PubMed ID: 17178763 [No Abstract] [Full Text] [Related] [Next] [New Search]